---
layout: post
title: "Practice Guidelines for the Administration of Buprenorphine for Treating Opioid Use Disorder"
date: 2026-02-05 19:09:26 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2021-08961
original_published: 2021-04-28 00:00:00 +0000
significance: 8.00
---

# Practice Guidelines for the Administration of Buprenorphine for Treating Opioid Use Disorder

**Published:** February 05, 2026 19:09 UTC
**Source:** Federal Register
**Original Published:** April 28, 2021 00:00 UTC
**Document Number:** 2021-08961

## Summary

The Practice Guidelines for the Administration of Buprenorphine for Treating Opioid Use Disorder provides eligible physicians, physician assistants, nurse practitioners, clinical nurse specialists, certified registered nurse anesthetists, and certified nurse midwives, who are state licensed and registered by the DEA to prescribe controlled substances, an exemption from certain statutory certification requirements related to training, counseling and other ancillary services (i.e., psychosocial services).

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2021/04/28/2021-08961/practice-guidelines-for-the-administration-of-buprenorphine-for-treating-opioid-use-disorder)
- API: https://www.federalregister.gov/api/v1/documents/2021-08961

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
